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Abstract
Introduction: To investigate the validity of using 670nm red light as a preventative treatment for Retinopathy of
Prematurity in two animal models of oxygen-induced retinopathy (OIR).
Materials and Methods: During and post exposure to hyperoxia, C57BL/6J mice or Sprague-Dawley rats were
exposed to 670nm light for 3 minutes a day (9J/cm2). Whole mounted retinas were investigated for evidence of
vascular abnormalities, while sections of neural retina were used to quantify levels of cell death using the TUNEL
technique. Organs were removed, weighed and independent histopathology examination performed.
Results: 670nm light reduced neovascularisation, vaso-obliteration and abnormal peripheral branching patterns of
retinal vessels in OIR. The neural retina was also protected against OIR by 670nm light exposure. OIR-exposed
animals had severe lung pathology, including haemorrhage and oedema, that was significantly reduced in 670nm
+OIR light-exposed animals. There were no significance differences in the organ weights of animals in the 670nm
light-exposed animals, and no adverse effects of exposure to 670nm light were detected.
Discussion: Low levels of exposure to 670nm light protects against OIR and lung damage associated with exposure
to high levels of oxygen, and may prove to be a non-invasive and inexpensive preventative treatment for ROP and
chronic lung disease associated with prematurity.
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Introduction
Retinopathy of Prematurity (ROP) is a disorder of the
developing retina, and one of the leading cause of blindness in
infants of the western world, contributing heavily to the social
and financial burdens caused by visual impairment worldwide
[1]. There are many risk factors leading to progression of ROP
including low birth weight, gestational age, supplemental
oxygen therapy, sepsis, blood transfusions, respiratory distress
syndrome and genetics [2–5]. However gestational age, low-
birth weight and supplemental oxygen are the widely accepted
major risk factors.
ROP has been described as a two phase disease, beginning
with delayed vascular growth after premature birth (Phase I –
hyperoxic phase), followed by the release of hypoxia stimulated
factors to stimulate new blood vessel growth (Phase II –
hypoxic phase) [6]. Supplemental oxygen is administered to
premature infants to maintain adequate oxygenation levels, to
overcome pulmonary insufficiency. Since being identified as a
risk factor for ROP, supplemental oxygen is now monitored
closely leading to a decrease in the number of infants
developing ROP. However, as the survival rates of very low
birth weight infants (VLBW) increase, so does the incidence of
ROP [7]. A number of clinical studies are underway to
determine the safe oxygen saturation levels at which premature
infants can be nursed to minimise the risk of ROP [8] and as a
result, a number of guidelines have been developed for
screening and treatment of ROP in premature and low birth
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weight infants [9]. Use of these guidelines significantly reduces
the risk of blindness and significant visual loss, but does not
prevent the disease from occurring, nor the other long-term
visual consequences of ROP.
Current therapies for ROP, including laser photocoagulation
or cryo-therapy to reduce the incidence of blindness, although
a number of long-term visual issues can still present post
treatment including reduced visual acuity [10], reduced visual
fields [11], reduced contrast sensitivity [12] and strabismus
[13]. All current treatments for ROP are invasive, expensive
and target only the angiogenic aspect of the disease, thus not
addressing the neuronal impacts or other long-term effects.
Thus there is a need for an inexpensive, non-invasive
preventative treatment for ROP.
Low-level Light therapy (LLLT) in the red to near-infrared
light spectrum (600-1000nm) protects against neuronal and
retinal cell damage [14], and 670nm red light has been shown
to be a powerful neuroprotectant, against light induced damage
[15,16] and toxins [17]. Treatment with 670nm red light
improves retinal healing [18] and modulates expression of
genes involved with inflammation, oxidative metabolism and
apoptosis [19]. Although the precise mechanism is unknown
there is strong evidence to suggest that cytochrome c oxidase
(CCO) acts as the primary photo-acceptor/chromophore [20],
boosting oxidative metabolism [21] and ATP production [22],
driving reparative and protective mechanisms.
Animal models for ROP are well established and include a
number of rodent models. These oxygen-induced retinopathy
(OIR) models have provided crucial insights into the
pathogenesis and underlying mechanism of ROP [23]. OIR
models take advantage of the fact that in some animals normal
retinal vascularisation occurs ex utero, and thus resemble the
incomplete vascular development of the retinal vasculature in
premature infants.
The aims of the present study were to use mouse and rat
models to evaluate the efficacy of 670nm red light to protect
against OIR. We hypothesise that treatment with 670nm red
light will be a novel preventative strategy for ROP, promoting
normal mechanisms of retinal vascularisation, reducing
oxidative and neuronal damage.
Materials and Methods
Animals
All work was conducted using either C57BL/6J mice or
Sprague-Dawley albino rats. All animal experimentation was
conducted in accordance to the ARVO (Association for
Research in Vision and Ophthalmology) statement for the Use
of Animals in Ophthalmic and Vision Research and with the
approval of the Animal Ethics Committee at the Australian
National University, Canberra (protocol-A2011/029). Animals
were raised and experiments conducted in cyclic 5 lux light
(12hrs: 12hrs). All animals were culled using cervical
dislocation. All culling was performed at 9am to control for
possible circadian effects.
For both the mouse and rat OIR models animals were
assigned to one of 4 groups; control (normal oxygen, no
670nm), 670nm (normal oxygen, 670nm treatment only), OIR
(oxygen only, no 670nm treatment) or 670nm+OIR (oxygen
and 670nm treatment). To adjust for litter size and cross-litter
variability all litters were maintained at 10 animals per
experimental group and 2 experimental groups per cage/dam
(control and 670nm, or OIR and 670nm + OIR). All experiments
were performed in biological triplicate (3 litters per experimental
group), with a minimum of 12 animals per experimental group.
Oxygen Induced Retinopathy Models
Mouse 75% oxygen model.  Animals were maintained in
normoxia until P7. At P7 dam and pups were placed in an
Oxycycler (Biospherix Ltd., Lacona, NY) with constant 24hrs
75% oxygen for 5 days. At p12 animals were removed from
oxygen and returned to normoxia until P17. At P17 animals
were culled and the eyes and organs harvested for further
investigation. Animal weights and lengths were measured daily
at 9am. Animals weighing less than 4g at P17 were excluded
from the study.
Rat 80%/21% oxygen model.  At birth (P0) pups and dam
were placed in an Oxycycler (Biospherix Ltd., Lacona, NY) with
24 hours cyclic oxygen, 80% for 22 hours: 21% (normoxia) for
2 hours. Animals were maintained this way until P18 when they
were culled, and the eyes and organs harvested for further
investigation. Animal weights and lengths were measured daily.
Animals weighing less than 30g at P18 were excluded from the
study.
670nm Red Light Treatment
Treated animals were exposed to 670nm red light only
during exposure to hyperoxia (P7-P17, mouse; P0 – P18, rat).
Animals were exposed to 670nm red light from a WARP 75
source (Quantum Devices Inc., Barneveld, WI) Each animal
was held approximately 2.5cm from the light source and
treated for 3 minutes daily. This arrangement provided a
fluence of 9J/cm2 at the eye. The animals did not appear
agitated by the red light. All treatments were performed at 9am.
Retinal Whole-mounts
Retinal whole-mounts were prepared using an established
technique [24] with slight modifications. Eyes were removed
and immediately fixed in 4% paraformaldehyde for 1 hour.
Following fixation the eyes were rinsed 3 times in phosphate
buffered saline (PBS). The retinas were removed from the
eyecup, and placed under a dissection microscope (Leica,
Wetzlar, Germany). To whole-mount the retina an ophthalmic
surgical blade was used to create four incisions 1mm from the
optic nerve head to the peripheral retina. Retinas were fixed in
4% paraformaldehyde for four hours then washed overnight in
PBS. Retinas were then washed with PBS for three intervals of
30 minutes and placed in a fluorescein isothiocyanate (FITC)
conjugated lectin stain (Sigma, St. Louis, MO) at a ratio of
1:100 with PBS for 24 hours, followed by rinsing with PBS for
three intervals of 30 minutes. Retinas were then whole-
mounted on slides and visualised using LSM 5 confocal
microscope (Carl Zeiss, Jena, Germany) and acquired using
PASCAL v 4.0 software (Carl Zeiss). Individual images were
stitched together to create whole retinal images and prepared
for publication using Adobe Photoshop CS4. Assessment of
670nm Protects against Retinopathy of Prematurity
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the neovascularisation and vaso-obliteration was performed as
a blinded assessment using a technique described previously
[24]. To quantify vaso-obliteration, lectin images were imported
into Adobe Photoshop, the avascular area selected and the
pixel density quantified. The number of pixels for the vaso-
obliteration was normalised against the total number of pixels
of the whole mount, giving a percentage of vaso-obliteration.
Neovascularisation was calculated using a macro in imageJ
[25] designed to specifically select areas of neo-
vascularisation. The number of pixels for the
neovascularisation was normalised against the total number of
pixels of the whole mount, giving a percentage of
neovascularisation. A one-way ANOVA with Tuckey’s post hoc
test was performed using Prism 5 (GraphPad Software) to
compare the effects of different treatment conditions.
Peripheral Branching
We used a recently submitted image processing method
(Barbosa and Maddess, manuscript in preparation) namely
Streamlined Morphological Image Analysis (SMIA) to
characterize the change in vessel arborisation due to different
treatments or conditions. SMIA features in 2D are related to
known geometric measures such as the Area, Perimeter and
the Euler number of a region. These quantities are monitored
while the region of interest is undergoing a variational
segmentation process called Chan-Vese [CV]. At critical points
of this process, the most rich shape representation of the
object occurs and we extract the features for SMIA,
automatically.
Having the SMIA geometrical features at hand we performed
a one way analysis of variance (MANOVA) using their principal
components in order to quantify the distance between the
treatment groups. We display the result hierarchically by
clustering the resulting Mahalanobis distance using a single
linkage (nearest neighbour) algorithm.
Organ Weights and Pathology
Following cervical dislocation, animals organs were
removed, weighed fresh then fixed in 10% neutral buffered
formalin (NBF) and analysed for any histological abnormalities.
The organs removed included the lungs, brain, kidney, liver,
spleen, heart and thymus. Pathology was assessed blind and
performed by an anatomical pathologist experienced in rodent
histology at the Canberra Hospital, Australia.
Cryosectioning and TUNEL
In some animals, the fellow eye was marked on the superior
aspect with a pen for orientation, enucleated and immersion-
fixed in 4% paraformaldehyde for 3 hours. The eye was then
washed in PBS three times and cryoprotected by immersion in
15% sucrose overnight. Eyes were sectioned at 12µm on a
cryostat in the superior-inferior axis.
Cell death was assessed by the TdT-mediated dUTP nick
end labelling (TUNEL) technique to identify the fragmentation
of DNA characteristic of apoptotic cells, following a previously
published protocol [26] but using a fluorophore, Alexa 594 for
visualisation. TUNEL-labelled sections were scanned from
superior to inferior edge and the number of TUNEL+ profiles in
each of the nuclear layers of the retina was recorded.
Frequency of TUNEL+ profiles/mm was averaged from at least
three sections per animal with 4 animals analysed. A one-way
ANOVA with Tuckey’s post hoc test was performed using
Prism 5 (GraphPad Software) to compare the effects of
different treatment conditions.
Results
Effects of 670nm on Vascular Development in Oxygen
Induced Retinopathy
Retinal whole-mounts from mice (Figure 1) and rats (Figure
2) revealed the modifications of retinal vascular development
typical of OIR paradigms, including vaso-obliteration,
neovascularisation and retinal haemorrhages. In the mouse
model vaso-obliteration occurs centrally, while in the rat model
it occurs on the retinal periphery. In both control and ‘NIR
alone’ animals, there was no adverse vascular development
(n=12). Quantification of both vaso-obliteration (Figure 3 A, C,
E and Figure 4 A–C) and neovascularisation (Figure 2 B, D and
F) showed that in mice retinas treated with 670nm there was a
significant decrease in the severity of vascular pathology
(n=12, p value < 0.05). In the rat vaso-obliteration was reduced
from 4.1% in OIR to 3.2% in OIR+670nm treated animals
(Figure 4C). In mice vaso-obliteration was reduced from 28.9%
in OIR to 20.0% (Figure 3E) in OIR+670nm animals, while
neovascularisation was reduced from 6.2% to 0.9% (Figure
3F). In mice the amount of retinal neovascularisation in OIR
retinas treated with 670nm was reduced to almost that of
control (Figure 3F) (n=12, p value = 0.0128).
The peripheral retinal vascular branching patterns in the
OIR-exposed animals were anomalous, including increased
tortuosity and disorganization in the peripheral vessel network
Figure 1.  P17 c57BL/6J mice retinal wholemounts stained
with lectin.  (A,E) Control and (B,F) 670nm alone mice retina
showed no observable difference in peripheral retinal
vasculature, while (C,G) OIR alone showed increaed vaso-
obliteration (indicated by +) and neovascularisation (indicated
by arrowheads). There was also an observable vascular
organisational difffernce in the OIR exposed retina (G). (D, H)
670nm+OIR, showed amelioration of neovascularisation, vaso-
obliteration and a more uniform vascular patterning. P –
postnatal day, OIR - Oxygen induced retinopathy. Scale A - D =
1mm, E -H = 200µm, I. Magnification of images E-H are 4x
original images.
doi: 10.1371/journal.pone.0072135.g001
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(Figure 1C,G, Figure 2C,G). Analysis of the retinal peripheral
vasculature branching patterns showed that OIR retinas had a
distinctive pattern of branching, compared to controls. The
cladistic analysis (Figure 5) indicates that OIR retinas clustered
Figure 3.  Quantification of vascular abnormalities in P17
c57BL/6J mouse lectin stained retinal wholmounts.  (A, B)
OIR shows increased vaso-obliteration (E) and
neovascularisation (F) compared to 670nm + OIR (C, D).
Neovascularisation was reduced to almost control levels in the
670nm+OIR retina (F). Red (A, C) areas show vaso-
obliteration, while white arrows show large neovascular tuffs
and white arrows show small tufts. * indicated statistical
significance p<0.05. Error bars show standard error. P –
postnatal day, OIR – Oxygen induced retinopathy. Graph bar
fills indicate controls (black), 670nm treated (dark grey), OIR
(light grey) and 670nm+OIR (white).
doi: 10.1371/journal.pone.0072135.g003
Figure 4.  Quantification of vaso-obliteration and cell death
in P18 Sprague-Dawley rats.  (A) OIR shows increased vaso-
obliteration (C) compared to 670nm + OIR (B). Red (A, B)
areas show vaso-obliteration. Representative images (D–E)
and quantification (H) of TUNEL images from the rat retina. To
maintain consistency representative images (D–E) were all
taken 500µm from the optic nerve head on the superior side of
the retina. Arrows indicate positive cell labelling in both the OIR
and 670nm+OIR animals. Control and 670nm (dark showed
little TUNEL positive labelling (H) in any of the retinal layers,
while experimental groups exposed to OIR showed increased
labelling compared to control levels (H). 670nm+OIR reduced
the level of labelling from that of OIR, but only with statistical
significance in the ONL (H). * indicated statistical significance p
<0.05. Error bars show standard error. Arrows indicate positive
cell labelling. GCL – ganglion cell layer, INL – Inner nuclear
layer, ONL – outer nuclear layer, P – postnatal day, OIR -
Oxygen Induced Retinopathy. Scale A,B = 1mm, D-G = 50µm.
Graph bar fills indicate controls (black), 670nm treated (dark
grey), OIR (light grey) and 670nm+OIR (white).
doi: 10.1371/journal.pone.0072135.g004
Figure 2.  P18 Sprauge-Dawley rat retinal wholemounts, stained with lectin.  (A,E) Control and (B,F) 670nm alone mice retina
showed no observable difference in peripheral retinal vasculature, while (C,G) OIR alone showed increaed vaso-obliteration
(indicated by +) and areas of retinal heamorrhages (indicated by an arrow). (D,H) 670nm+OIR showed amelioration of vaso-
obliteration and control like vascular patterning. P – postnatal day, OIR - Oxygen induced retinopathy. Scale A-D = 2mm, E-H =
650µm. Magnification of images E-H are 4x original images.
doi: 10.1371/journal.pone.0072135.g002
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separately from the other three experimental groups, and that
670nm+OIR retinas have a peripheral branching pattern that is
closely related to that seen in controls and 670nm.
Furthermore, quantification of the number of rat retinal
haemorrhages (Figure 6) shows that rats subjected to the OIR
paradigm, but also treated with 670nm light had relatively few
retinal haemorrhages, statistically different from OIR alone
(n=12, p value = 0.0135).
Effects of 670nm on Photoreceptor Cell Death in
Oxygen Induced Retinopathy
Natural cell death is a normal feature of retinal development
and, as expected, there were TUNEL positive cells present in
control and ‘NIR only’ samples; these values were not
statistically different from each other (n=12, p value > 0.05).
Analysis of retinal cell death (rat model) showed a significant
increase in the overall amount of cell death in retinas exposed
to the OIR paradigm (Figure 4 D–H) (n=12, p values < 0.05).
The data also show that retina from 670nm+OIR animals had
reduced levels of cell death in all retinal layers, compared with
OIR alone (Figure 4H), however only in the outer nuclear layer
(ONL) was this found to be statistically significant (n=12, p =
0.018). This indicates that 670nm was able to protect against
OIR in the ONL layer of the retina.
Effects of 670nm on Growth and Organ Development in
Mice Raised in Normoxia
No changes in length were noticed in the animals (control
n=27, treated n=21) during 21 days of monitoring (Figure 7B).
However, we detected an increase in the weight of the treated
animals between P12 – P21 days (Figure 7A; p value < 0.05)
which was no longer evident in animals allowed to develop to
adulthood. Analysis of organ weight (control n=27, treated
n=21) showed no difference in the 670nm treated animals
(Figure 7D), except for the lungs which were significantly
heavier in the 670nm treated animals (p value < 0.05).
Histopathological analysis of the organs showed no difference
between the experimental groups. We also noted that in the
group of mice treated with 670nm light there was a reduced
mortality rate; 27% in controls, 15% in 670nm treated mice
(Figure 7C). In animals allowed to develop to adulthood
following 670nm red light treatment there were no adverse
findings in organs, or overall size of the animals.
Organ Development in Oxygen Induced Retinopathy
In normal development of the control rats, eyes were open
by P14 in 100% of animals (n=24). In rats exposed to the OIR
paradigm eye-opening was delayed, such that only 50% of
animals had opened their eyes by P15, and 100% at P16
(n=12). Eye opening occurred earlier in groups treated with
670nm light, such that 60% of rats treated with 670nm alone
(n=12) opened eyes by P13, and 25% of 670nm+OIR (n=12)
had open eyes by P14. Rats exposed to the OIR paradigm had
reduced weight and length compared to controls; exposure to
670nm light did not modify this. There was no effect of 670nm
light treatment alone on normal animal weight and length.
Both the kidneys and livers of rats exposed to the OIR
paradigm were reduced in size compared to controls (Figure
8A) (p < 0.05), although histopathological analysis showed no
differences in most of the organs. An exception was the lungs;
rats exposed to the OIR paradigm had increased numbers of
haemorrhage and areas of oedema compared to controls.
Significantly, lung pathology in 670nm+OIR rats were
consistent with control (Figure 8B).
Discussion
This is the first study to demonstrate that 670nm red light
therapy of neonatal animals can modify the adverse outcomes
of exposure to high levels of oxygen and protects the retina
from OIR. Furthermore, the data show that in rats treatment
with 670nm red light for short exposures (3 minutes a day) for
18 days does not induce pathology in major organs or any
Figure 5.  Analysis of peripheral vessel branching patterns
in the mouse OIR model.  The hierarchical clustering diagram
indicates a divergence from the experimental groups with the
largest divergence occurring with the OIR group. The
Mahalanobis distance was calculated from a MANOVA
procedure and is shown relative to control. The OIR group
clusters alone (1.96 distance) indicate a very different pattern
of peripheral vasculature, to the other experimental groups.
670nm+OIR (0.46 distance) reduced the alteration in the
peripheral patterning to almost that of control and 670nm (0.32
distance). The length of the lines in the hierarchical clustering
diagram indicate the relative difference between groups.
doi: 10.1371/journal.pone.0072135.g005
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alterations in normal development. When administered in
conjunction with an OIR paradigm, the present study shows
that in both the mouse OIR paradigm, and the rat OIR
paradigm, 670nm red light treatment (i) reduces vaso-
obliteration in the retinal vasculature; (ii) reduces
neovascularization and retinal haemorrhage; (iii) preserves
retinal vascular branching architecture, and (iv) reduces the
incidence of neural cell death. Furthermore, we find that
treatment of OIR rats with 670nm red light reduces the
incidence of lung pathology to levels that are comparable with
controls.
The animal models used in this study are established models
for mimicking the sort of pathologies seen in ROP (reviewed in
23), with strengths and weaknesses to both models. The
differences between the mouse and rat OIR models include
differences in the patterns of vaso-obliteration, such that in the
mouse OIR model vaso-obliterations occur centrally, around
the optic disc [27], while in rats the vaso-obliteration occurs in
the periphery [28], as they do in human infants. The mouse
model, however, is better suited to quantifying changes in
levels of neovascularisation [27]. The retina of albino neonates
(reviewed in 29 also respond differently to fluctuations of
oxygen [30] and have developmental mutations, such as the
inability to regulate retinal cell cycle [31]. Despite these
differences we observed a similar and significant reduction in
the severity of vaso-obliteration in both rat and mouse OIR
animals treated with 670nm red light.
Figure 6.  Number of retinal haemorrhages in the rat
oxygen induced retinopathy animals.  The number of
haemorrhages was reduced from 2.3 per retina in the OIR
animals to 0.4 in the 670nm+OIR animals. The 670nm+OIR
was not statistically significant from controls, but was from OIR
animals (* indicates a p-value < 0.05). OIR – Oxygen Induced
Retinopathy. Graph bar fills indicate OIR (light grey) and
670nm+OIR (white).
doi: 10.1371/journal.pone.0072135.g006
ROP involves vaso-obliteration and neovascularisation, and
in the worst cases results in neural damage, retinal detachment
and blindness [6,32]. The hyperoxic phase of OIR results from
inspired oxygen being administered to neonates in order to
maintain normal oxygen saturations in infants affected by lung
disease of prematurity. Although, inspired oxygen therapy does
not account for all occurrences of ROP, it is widely accepted as
one of the key factors in the pathogenesis of the disease [2,33].
This makes the OIR models useful for studying changes in
retinal pathology due to exposure to increased (mouse) or
fluctuating (rat) oxygen levels. Our results suggest that the
severity of the hypoxic phase of ROP can be reduced, by
maintaining a normal vessel development during the hyperoxic
phase, thus reducing the impact of hypoxia on return to room
air.
It is unclear how normal development of the retinal
vasculature is maintained by 670nm red light in these models
of OIR. This is largely because the precise mechanism
underling the effect of LLLT is largely unknown. The most
widely accepted hypothesis is that cytochrome c oxidase is the
photoacceptor for 670nm red light [20,22,34,35], and promotes
an increase in oxidative metabolism (reviewed in 36). Thus it is
suggested that 670nm red light acts to promote mitochondrial
function, increasing oxygen usage, reducing oxidative damage,
Figure 7.  Animal weight (A), length (B), mortality rate (C)
and organ weight (D) taken daily in animals exposed to
670nm compared to controls in normal atmospheric
oxygen.  (A) From P12 there was a statistically significant (*
indicated p<0.05) deviation from normal weight gain with
animals gaining weight at an increased rate. (B) There were no
noticeable differences in the length of the animals over the 21
day period. (C) There was no change in the weight of the
organs investigated except for the lungs which showed a
significant increase in weight (* indicates p < 0.05). (D) 670nm
red light appears to reduce the mortality rate from 27% in
controls (n=27) to 15% in the 670nm (n=21) exposed animals
(* indicates p<0.05). All animals were raised in normal
atmospheric oxygen. Littermates were used to reduce
variability across litters. Graph bar fills indicate controls (grey
bars), 670nm treated (white bars).
doi: 10.1371/journal.pone.0072135.g007
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and increasing ATP production [37,38]. This hs been shown in
number of non-neuronal cells, such as astrocytes [39] and
fibroblast [40] however has been most effective in CNS tissue
(reviewed in 36). This is probably due to the high metabolic
demands of neuronal tissue, and subsequent susceptibility to
damage as a result of fluctuations in oxidative metabolism. In
these OIR models it is possible that 670nm red light promotes
consumption of the excess oxygen available in the hyperoxic
phase of the disease, making oxygen levels in the tissues
closer to normoxia, and facilitating more normal development
of the retinal vasculature.
Establishing normoxia in the retinal microenvironment
implies a moderation of the oxidative stress conditions that
result from hyperoxia. Indeed recent experiments show that in
adult mice exposed to hyperoxia, levels of acrolein and
haemoxygenase, both markers of oxidative stress, are
significantly reduced in the retina by exposure to 670nm red
light (Albarracin, manuscript in preparation). A reduction in
oxidative stress may also explain reduced natural cell death in
the retina, and could minimise damage [9] to organs
susceptible to fluctuations in oxygen levels, including the lungs.
While the present results support this hypothesis, more work is
required to understand the mechanism/s of action of 670nm
red light. An alternative hypothesis is that neuroglia cells,
including astrocytes, which are damaged by OIR experimental
conditions [41] are protected by 670nm red light exposure
during the hyperoxic phase, preserving normal processes of
vascular development. This idea is consistent with previous
findings that 670nm red light exposure moderates the
expression of inflammatory markers and complement in retinal
degeneration induced by bright light [42].
Figure 8.  Assessment of the organ weights and lung
pathology of rats exposed to either OIR, 670nm or
both.  There was no change in the weights of animals exposed
to 670nm from control (A). The OIR animals showed a
statistically significant decrease in organ weight in both the
kidneys and liver (* indicates p <0.05). There was an increase
in the number of lung pathology (B) presentations (both
haemorrhages and oedema) in the OIR exposed animals. This
was ameliorated by 670nm exposure compared to control
levels. 670nm alone showed no change from control levels.
670nm treated OIR animals did not show any difference from
OIR levels. OIR – Oxygen Induced Retinopathy. Graph bar fills
indicate controls (black), 670nm treated (dark grey), OIR (light
grey) and 670nm+OIR (white).
doi: 10.1371/journal.pone.0072135.g008
Finally, photoreceptor dysfunction and retinal cell death have
been reported in OIR animal models [43] and in ROP [44].
Neuroprotection is therefore an important aspect for evaluation
of ROP treatment and management. This study shows that the
neural retina, and specifically the photoreceptors, are protected
from cell death and OIR by 670nm red light therapy. Such
protection of photoreceptors is consistent with other models,
including the rodent light damage model [45], indicating that
oxidative damage is a common feature in photoreceptor death
[15,16,19]. Excessive white light [45] and certain wavelengths
of light [46] have been shown to be toxic to photoreceptors,
however there is no evidence to suggest 670nm is damaging to
photoreceptors [15,16,18,19,42]. This is possibly due to the
mechanisms of phototoxicity and photobiomodulation being
different with white light acting on the photopigments, leading
to lipid peroxidation and oxidative stress [47] and 670nm red
light acting on the cytochrome c oxidase promoting efficient
mitochondrial function.
Although not the focus of this study our findings indicate that
670nm treatment may be beneficial in the management of
other complications of prematurity, in particular Chronic Lung
Disease (CLD). Hyperoxic and hypoxic states also influence
the development of CLD [48], which in turn contributes to
vulnerability to ROP because of the fluctuations in arterial
oxygenation related to the lung disease and oxygen treatment
required to maintain normal saturations. It is possible that
670nm red light may reduce the severity of CLD, by reducing
inflammation and stabilising lung development and
alveolarisation during hyperoxia, resulting in more ordered
vascular development, and fewer haemorrhages. Systemic
changes to inflammation have been described in a recent study
[49] where inflammatory markers were modulated following
low-level-laser therapy (660nm) treatment in an animal model
of heart failure. This study supports these previous findings that
systemic changes to biology, and specifically inflammation, can
occur from localised LLLT and presents the first indication that
670nm red light can protect the lungs from CLD. Indeed, we
suggest that such a decrease in inflammation and increase in
metabolic efficiency explains the decreased mortality of mice
treated with 670nm red light. However, further work is required
to document the influences of 670nm red light on lung
development and neonatal survival.
Conclusion
As modern-medicine pushes the survivability limits of pre-
term babies, we must endeavour to find solutions to the
complicated problems associated with lower preterm
survivability, such as the increased incidence and severity of
ROP. Exposure to 670nm red light is a potential novel, non-
invasive and inexpensive treatment for the prevention and
moderation of ROP.
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